Tryptophan and Kynurenine Pathway Metabolites and Psychoneurological Symptoms Among Breast Cancer Survivors
- 10 October 2022
- journal article
- research article
- Published by Elsevier in Pain Management Nursing
- Vol. 24 (1) , 52-59
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Nursing Research (K23NR018482, L30NR020114)
- NCCIH (K24AT011995, K24NR015340)
- National Institutes of Health
This publication has 62 references indexed in Scilit:
- Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivorsBrain, Behavior, and Immunity, 2013
- Common Biological Pathways Underlying the Psychoneurological Symptom Cluster in Cancer PatientsCancer Nursing, 2012
- Association between pro- and anti-inflammatory cytokine genes and a symptom cluster of pain, fatigue, sleep disturbance, and depressionCytokine, 2012
- Fatigue in Patients with Lung Cancer Is Related with Accelerated Tryptophan BreakdownPLOS ONE, 2012
- Kynurenine 3-Monooxygenase Inhibition in Blood Ameliorates NeurodegenerationCell, 2011
- Pre‐treatment symptom cluster in breast cancer patients is associated with worse sleep, fatigue and depression during chemotherapyPsycho-Oncology, 2008
- Fatigue in long‐term breast carcinoma survivorsCancer, 2006
- Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism?Cancer, 2003
- Estimating the Dimension of a ModelThe Annals of Statistics, 1978
- A new look at the statistical model identificationIEEE Transactions on Automatic Control, 1974